ALNYLAM PHARMACEUTICALS INC - NOTE 1.000% 9/1

Historical Portfolio Holders from Q3 2023 to Q1 2024

All holders as of March 31, 2024: Q1 2024
Type / Class: Debt / NOTE 1.000% 9/1
Principal, excl. options Q1 2024: 875 M
Holdings value Q1 2024: $826 M
Value change Q1 2024: +$33.1 M
Grand Portfolio weight change Q1 2024: +0%
Number of holders: 65
Number of buys Q1 2024: 30
Number of sells Q1 2024: -34
Average buys Q1 2024 %: +0.001%
Average sells Q1 2024 %: -0.001%
CUSIP: 02043QAB3

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Principal	Value	Change	Price	Investors
2024 Q1	$875 M	$826 M	+$33.1 M	$0.94	65
2023 Q4	$859 M	$836 M	+$31.5 M	$0.99	63
2023 Q3	$810 M	$776 M	+$707 M	$0.93	52